Trials / Unknown
UnknownNCT05291455
Lacosamide in Neonatal Status Epilepticus
Efficacy of Lacosamide in Neonatal Status Epilepticus: A Randomized Controlled Study
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Sherief Abd-Elsalam · Academic / Other
- Sex
- All
- Age
- 28 Days
- Healthy volunteers
- Not accepted
Summary
Lacosamide in neonatal status epilepticus
Detailed description
The study will assess the efficacy of Lacosamide in neonatal status epilepticus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lacosamide | lacosamide will be given |
| DRUG | Phenobarbital | phenobarbital will be given |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2024-03-01
- Completion
- 2024-04-01
- First posted
- 2022-03-22
- Last updated
- 2022-03-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05291455. Inclusion in this directory is not an endorsement.